Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal Cancer

NCT01038544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-06-22

No results posted yet for this study

Summary

The purpose of this study is determine if performing endobronchial ultrasound (EBUS) in addition to standard endoscopic ultrasound (EUS) can increase the precision and accuracy of staging esophageal cancer in comparison to EUS alone. The expectation is that EBUS can be used to biopsy lymph nodes that: (1) because of their position in the mediastinum would be inaccessible to EUS, or (2) would be inaccessible due to their position behind the esophageal tumor.

Conditions

  • Esophageal Cancer

Interventions

PROCEDURE

Endoscopic Ultrasound (EUS)

Minimally Invasive Echo-Endoscopic Lymph Node Evaluation and Biopsy

PROCEDURE

Endobronchial Ultrasound (EBUS)

Minimally Invasive Echo-Bronchoscopic Lymph Node Evaluation and Biopsy

Sponsors & Collaborators

  • C.E.T.O.C. - CHUM Endoscopic Tracheobronchial and Oesophageal Center

    collaborator UNKNOWN
  • Marcel and Rolande Gosselin Chair in Thoracic Surgical Oncology

    collaborator UNKNOWN
  • Fonds de la Recherche en Santé du Québec

    collaborator OTHER_GOV
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal

    collaborator OTHER
  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Moishe Liberman, MD, PhD · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01038544 on ClinicalTrials.gov